Slide 1: Transaction Overview
TRANSACTION OVERVIEW Reffind Limited enhances Wooboard by entering in to a product Licensing Agreement with World leading biometrics software solutions provider, InterBIO Wooboard in conjunction with InterBIO’s technology solutions are ideally placed to facilitate a safe and productive working envir
Slide 2: Key Highlights
KEY HIGHLIGHTS The InterBIO transaction per today’s adjoining ASX announcement enables Reffind to enhance the features of its existing employee engagement and reward offering WooBoard and its applications to remote working and other verticals. InterBIO is a world leading identity management and soft
Slide 3: InterBIO and Transaction Overview
INTERBIO AND TRANSACTION OVERVIEW About InterBIO Established in 2011, InterBIO is one of the world's leading identity management biometric software solutions companies with state of the art technology and a robust platform supported by its core team in Indonesia and India (markets in which InterBIO
Slide 4: InterBIO's Bespoke Technology Platforms
INTERBIO’S BESPOKE TECHNOLOGY PLATFORMS InterBIO has an extensive product suite that will be licenced to Reffind under the terms of the License Agreement. The versatility and cutting edge nature of the InterBIO product range ensures Reffind is uniquely enabled to target a multitude of high-growth se
Slide 5: Platforms Leveraged into Significant and High-Growth Markets
PLATFORMS LEVERAGED INTO SIGNIFICANT AND HIGH-GROWTH MARKETS COVID-19 is accelerating the need for identification and authentication technology across the world, as evidenced by the contracts InterBIO has entered with the Indonesian government. InterBIO’s platforms are ideally placed for large scale
Slide 6: COVID-19: A Transformational "Adoption Driver"
COVID-19: A TRANSFORMATIONAL “ADOPTION DRIVER” COVID-19 has presented significant challenges for Quarantine Management healthcare providers, Problem Solution governments and businesses COVID-19 is creating new InterBIO enables the following: globally requirements for governments/ • Enforce quarantin
Slide 7: InterBIO's Platforms Have Significant Operational and Commercial Validation
INTERBIO’S PLATFORMS HAVE SIGNIFICANT OPERATIONAL AND COMMERCIAL VALIDATION InterBIO has spent a decade developing and refining its bespoke platforms which can be purchased “off-the-shelf” or further customised prior to deployment InterBIO in the field Indonesian Government DBS Bank – Singapore Telk
Slide 8: Significant Synergies from WooBoard Integration
SIGNIFICANT SYNERGIES FROM WOOBOARD INTEGRATION Reffind’s WooBoard platform provides corporations with an intuitive employee recognition and engagement platform. InterBIO’s capabilities can be seamlessly integrated into WooBoard as an expansion of its current offering to now provide secure employee
Slide 9: Contact Details
CONTACT DETAILS Company Enquiries Declan Jarrett, Company Secretary Reffind Limited declan.jarrett@reffind.com Media Enquiries Daniel Paperny Media & Capital Partners daniel.paperny@mcpartners.com.au InterBIO Transaction Overview 9
Slide 10: Disclaimer
DISCLAIMER This investor presentation (Presentation) has been prepared by Reffind Limited (Company). NOT AN OFFER This Presentation is for information purposes only. This Presentation does not comprise a prospectus, product disclosure statement or other offering document under Australian law (and wi